P2B-101

State Health Centre Oncology Department (Budapest, Hungary) › P2B-101

P2B-101

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2013-04-17

withdrawn

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 neutropenia with onset in cycle 2 (2013-06-02); assessed as related to study drug (probable); resolved 2013-06-11.

mild assessed

Grade 2 alopecia with onset in cycle 1 (2013-05-21); assessed as related to study drug (probable); not resolved at last follow-up.

moderate assessed

Grade 3 leukopenia with onset in cycle 1 (2013-05-13); assessed as related to study drug (probable); resolved 2013-05-19; action: drug interrupted.

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.